What is the story about?
Shares of CESC declined on Thursday, November 5, after the company reported its second quarter results.
The company reported a marginal decline in its consolidated net profit for the September quarter, with its profit after tax (PAT) falling 1.2% to ₹423 crore compared with ₹428 crore in the corresponding quarter last year.
Revenue from operations increased 6.5% to ₹5,607 crore in the seocnd quarter, from ₹5,267 crore in the year-ago period.
The company's earnings before interest, taxes, depreciation and amortisation (EBITDA) declined 2.1% to ₹1,039 crore from ₹1,061 crore in the previous fiscal. Its EBITDA margin contracted by 150 basis points to 18.5% from 20% a year earlier.
On another note, previously, CESC had declared an interim dividend of ₹6 per equity share on August 13, 2026, which was paid during the September quarter.
Shares of CESC came under pressure following the September quarter earnings. The stock, which touched an intraday high of ₹135.20, was trading in the red at ₹130.40, down 0.41%, around 11:55 am.
The stock has declined around 2% over the past month and is down 21.6% so far this year.
Also Read: Hester Biosciences Q2 Results: Shares jump 8% after profit rises 41%, revenue grows 38%
The company reported a marginal decline in its consolidated net profit for the September quarter, with its profit after tax (PAT) falling 1.2% to ₹423 crore compared with ₹428 crore in the corresponding quarter last year.
Revenue from operations increased 6.5% to ₹5,607 crore in the seocnd quarter, from ₹5,267 crore in the year-ago period.
The company's earnings before interest, taxes, depreciation and amortisation (EBITDA) declined 2.1% to ₹1,039 crore from ₹1,061 crore in the previous fiscal. Its EBITDA margin contracted by 150 basis points to 18.5% from 20% a year earlier.
On another note, previously, CESC had declared an interim dividend of ₹6 per equity share on August 13, 2026, which was paid during the September quarter.
Shares of CESC came under pressure following the September quarter earnings. The stock, which touched an intraday high of ₹135.20, was trading in the red at ₹130.40, down 0.41%, around 11:55 am.
The stock has declined around 2% over the past month and is down 21.6% so far this year.
Also Read: Hester Biosciences Q2 Results: Shares jump 8% after profit rises 41%, revenue grows 38%
/images/ppid_59c68470-image-179386252255359601.webp)

/images/ppid_59c68470-image-179359754937118171.webp)
/images/ppid_59c68470-image-179362512778525597.webp)
/images/ppid_59c68470-image-179363002631482437.webp)
/images/ppid_59c68470-image-179369511575226654.webp)
/images/ppid_59c68470-image-179386258380580547.webp)
/images/ppid_59c68470-image-179386002726555987.webp)
/images/ppid_59c68470-image-179369260887186144.webp)
/images/ppid_59c68470-image-179385269035248788.webp)
/images/ppid_59c68470-image-179379002747985612.webp)
/images/ppid_59c68470-image-179360252535947458.webp)
/images/ppid_59c68470-image-17936150827278828.webp)
/images/ppid_59c68470-image-179362752509788758.webp)